To further expand the model that PP2A activity is required for the apoptosis sensitivity of kinase inhibitor‐treated brain tumor cells, we used MB cell lines with heterogeneous AKT and PDK basal activity (Fig. S2B). The gene discussed is PTPA; the disease is brain neoplasm.